[PDF] Top 20 Current and emerging therapy for the management of vitiligo

... The xenon chloride excimer laser emits a wavelength of 308 nm. The excimer laser has some useful technical char- acteristics like an articulated arm and variable spot size. It is possible to selectively turn the beam of ... See full document

... nomodulatory therapy and the advent of more targeted therapies are both an opportunity and a ...and emerging therapies so that treatment decisions can be informed and appropriate to the ... See full document

... discusses emerging techniques such as intralesional cryotherapy, intralesional 5-fluorouracil, interferon, and ...the current spectrum of excessive scar treatment in the near ...photodynamic therapy, ... See full document

... While the effects of HSCT on Hurler syndrome are well established, HSCT for the treatment of other MPSs, particu- larly the effect on the neurologic deficits, has yet to be fully elucidated. The delayed presentation of ... See full document

... Abstract: Pancreatic adenocarcinoma carries a dismal prognosis and remains a significant cause of cancer morbidity and mortality. Most patients survive less than 1 year; chemotherapeutic options prolong life minimally. ... See full document

... Abstract: Wiskott–Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency disorder characterized by the triad of eczema, thrombocytopenia, and severe and often recurrent infections. Despite the rarity of this ... See full document

... combination therapy of N-Pd group (nivolumab, pomalidomide and dexamethasone, the investigational arm), Pd group (pomalidomide and dexa- methasone, the control arm) and NE-Pd group (elotuzumab, nivolumab, ... See full document

... included in the REMADHE trial (prospective, randomized, single-center open parallel trial; designed to compare a dis- ease management program versus control in patients with chronic heart failure). Patients were ... See full document

... Abstract: Myasthenia gravis (MG) is an autoimmmune disease in which autoantibodies to different antigens of the neuromuscular junction cause the typical weakness and fatigability. Treatment includes anticholinesterase ... See full document

... of therapy and monitor treatment ...rapidly emerging fi eld with novel technologies capable of monitoring the evolution of treatment relevant alterations such as those in DNA damage repair genes for poly ... See full document

... Abstract: Friedreich ataxia (FRDA) is the most common autosomal recessive ataxia. Oxidative damage within the mitochondria seems to have a key role in the disease phenotype. Therefore, FRDA treatment options have been ... See full document

... DR is which may lead to legal blindness and it is a major public health problem. Early detection through screening, educating the population and timely intervention may decrease the complications in the course of ... See full document

... radiation therapy, cardiac surgery, and percutaneous procedures have become important ...and management of compli- cations such as pericardial effusion or ...and management of acute pericarditis. We ... See full document

... to therapy with evidence that African and Hispanic lupus nephritis patients respond less well to intravenous CYC than Caucasian or Asian patients, thus MMF may be a more prefer- able choice for induction ... See full document

... antiplatelet therapy, or those with active cardiac comorbidities), to whom dabigatran may still be prescribed, are often excluded from study populations or not adequately represented to formulate confident ... See full document

... standard therapy, belimumab, a fully human monoclonal antibody that specifically binds to and neutralizes the B-lymphocyte stimulator (BLyS or B-cell-activating factor (BAFF)), was well tolerated but reportedly ... See full document

... non-surgical management (physical therapy, rehabilitation, bracing and splinting), surgical management (intramedullary rod positioning, spinal and basilar impression surgery) and ... See full document

... Another thiazide-like diuretic, indapamide, was tested in two clinical trials. The Hypertension in the Very Elderly Trial (HYVET) was conducted to assess the benefits and risks of BP-lowering agents in the elderly ... See full document

... Glial tumors, particularly high grade glioma and glioblastoma multiforme (GBM), continue to pose a significant challenge to neuro-oncologists and neurosurgeons. Despite vigorous research efforts over the past ... See full document

... Several resources have been developed during the set-up of this trial that may be helpful for other researchers wishing to conduct trials of home light therapy, or for health providers wishing to implement the ... See full document